First human tests begin for new breast cancer drug alternative
Knowledge-focused
Recruiting now
This early-stage study aims to check if a new drug called KSHN001034 is safe and behaves similarly in the body to an existing breast cancer medication. The study will involve 40 healthy postmenopausal women who will receive either the new drug or the existing one. Researchers wil…
Phase: PHASE1 • Sponsor: Kashiv BioSciences, LLC • Aim: Knowledge-focused
Last updated Mar 12, 2026 13:52 UTC